首页> 外文期刊>Клиничесκая лабораторная диагностиκа >Method for determining leukocytic lipid-releasing capacity in the diagnosis of mechanisms responsible for atherogenesis in patients with coronary heart disease and ischemic stroke
【24h】

Method for determining leukocytic lipid-releasing capacity in the diagnosis of mechanisms responsible for atherogenesis in patients with coronary heart disease and ischemic stroke

机译:在冠心病和缺血性中风患者动脉粥样硬化形成机制的诊断中测定白细胞脂质释放能力的方法

获取原文
获取原文并翻译 | 示例
           

摘要

The authors have studied the mechanism responsible for neutrophilic accumulation and release of protein-lipid complexes in patients with atherosclerosis and the clinical value of this reaction. They present the results of experimental studies and clinical observations in the groups of patients with ischemic stroke, coronary heart disease, bronchial asthma, chronic obstructive pulmonary disease, and rheumatoid arthritis. Whether the process of neutrophilic and release of protein-lipid can be in vitro modulated in a 3-day culture has been demonstrated. The high diagnostic value of the method for determining the lipid-releasing capacity of leukocytes is shown. Some proteins involving in the formation of pathogenic protein-lipid complexes are identified. There is evidence for the use of new differential criteria for visceral diseases originating from atherosclerosis.
机译:作者研究了动脉粥样硬化患者中嗜中性粒细胞积累和释放蛋白-脂质复合物的机制,以及该反应的临床价值。他们介绍了缺血性中风,冠心病,支气管哮喘,慢性阻塞性肺疾病和类风湿关节炎患者的实验研究结果和临床观察结果。已经证明了在3天的培养中嗜中性粒细胞的过程和蛋白质脂质的释放是否可以在体外被调节。显示了用于确定白细胞的脂质释放能力的方法的高诊断价值。确定了一些与致病性蛋白质-脂质复合物形成有关的蛋白质。有证据表明,对于源自动脉粥样硬化的内脏疾病使用了新的鉴别标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号